Edesa Biotech is trading 5.4% up at $4.46 amid broad market gains.

  • It closed at $4.23 on September 11, 2026. No new company-specific announcement was listed in Edesa’s newsroom for September 11; its latest release was the August 19 public-offering pricing announcement.
  • The S&P 500, Nasdaq Composite, and Dow Jones rose 0.85%, 0.88%, and 0.97%, respectively.
  • Edesa is scheduled to participate in the H.C. Wainwright conference September 12–13.